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1. Introduction 
The scope of the chapter is to describe principles and mechanisms of activation and 
regulation of porcine intestinal immune system, especially during postnatal development. 
The pig is an essential source of food Worldwide, and thus, immunological research in 
swine husbandry and nutrition is performed to develop a safe and sustainable meat 
production. The study of the swine mucosal immune system is important because induction 
and maintenance of protective immune mechanisms will be at the cost of energy which will 
be lost for productive purpose. Also, certain degree of mucosal immune response is 
necessary to protect against chronic and acute infectious diseases that can cause losses in 
production, but on the other side, overacting immune responses can be detrimental for the 
host. Further, the pig is important biomedical model for applied experimental studies in 
different areas of physiology or clinical medicine. In particular, the pig is important for 
transplantation research, both for the development of surgical techniques and as 
xenotransplant donor. Thus, it is of importance to understand porcine immunology and to 
obtain insight into the structure and functional characteristics of their humoral and cellular 
immune system, both systemic and local. Herein, we propose the pig as a model for 
immunoregulation at the mucosal surfaces of the gut. The gut and gut associated lymphoid 
tissue (GALT) has dual roles in mammals organism: digestion and apsorption of nutrients 
as well as protecting the body from harmful pathogens and inducing tolerogenic responses 
to self-antigens, food particles and commensals. The unique architecture of the GI tract 
facilitates both of these functions.The purpose of this chapter is to review the existing 
literature on developmental aspects of antigen handling and processing by intestinal 
mucosal immune system of developing pigs.  
The immune defence system of the gut consists of lymphoid tissues and cells distributed along 
the gastrointestinal tract. Important features that characterize the mucosal immune system are: 
• Mucosa-associated lymphoid tissue (MALT or GALT-gut associated lymphoid tissue) 
with local and regional lymph nodes (LNs) where the induction of immune responses is 
established (Payer's patches and the mesenterial lymph nodes) 
• Certain subpopulation of lymphoid cells at the mucosal surfaces 
• Mucosal homing, that means specific recirculation of mucosal lymphocytes towards 
mucosae 
• Predominant mucosal immunoglobulin is IgA secreted at the mucosal surface. 
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2. Intestinal mucosal immune system (IMIS): Paradoxycal role to protect 
and/or tolerate  
The concept of mucosal immunity includes response to harmful antigens and also control of 
harmless antigens to prevent inflammation, well known as mucosal or oral tolerance. 
Therefore the mucosal immune system has to retain the ability to respond actively to 
pathogens, while avoiding active potentially inflammatory responses to pathogens. For that 
reason, the organisms have decision-making pathways embedded with the immunological 
architecture of the mucosal immune system. If a little dietary antigen access to the general 
circulation a systemic immune response may be prevented by the activities of regulatory T 
cells. Oral tolerance develops to the antigen. It involves either cellular suppression or clonal 
anergy and it is directed against Th1 cells (Gad, 2005). Which mechanism would be involved 
depends on several things. The feeding of novel protein antigens is associated with the 
presence of mucosal IgA responses despite the appearance of systemic oral tolerance. There 
is a strong genetic influence on the extent of systemic tolerance induced by feeding. Dose of 
orally administered antigen is important. Low doses invoke priming; high doses provoke 
clonal anergy (oral tolerance). Several studies, including humans, swine and mice, 
demonstrated that small quantities of food proteins absorb intact across the intestinal 
epithelium in adults and neonates (Bailey et al, 1994; Telemo et al, 1991). Recent studies of 
the phenomenon of oral tolerance suggest that it is variable and age-dependent (Bailey & 
Haverson, 2006) as well as the present of commensal microbial flora in the intestine.  
2.1 Structure of the intestinal mucosal immune system (IMIS) 
The mucosal immune system is described as the subset of immunological components, 
which appear in or associated with mucosal tissues. In mammals, there is clear distinction 
between primary lymphoid tissue, such as the bone marrow and the thymus, and secondary 
lymphoid tissue such as the spleen and organised lymph nodes and Payer’s patches. Since 
mucosal tissues are exposed to the harmless and harmful antigens, mechanisms must activate 
appropriate, but different responses to different types of antigens. Therefore we use classic 
differentiation mucosal immune system on the organised and the diffuse lymphoid tissues. 
The organised lymphoid tissues include the Payer’s patches and the mesenteric lymph 
nodes. There’s role is recognition of luminally presented antigens through different 
pathways: 
1. Some antigens cross the epithelium membrane of the villi owing the dendritic lineage 
which are underneath the intestinal epithelium. Dendritic cells with dendrites uptake 
antigen through the epithelium by manipulation tight-cell junction (Rescigno et al., 
2001, MacPherson & Uhr, 2004). Dendritic cells may also phagocytose epithelial cells 
together with environmental antigens (Huang et al., 2000) or ensure crossing the 
epithelium intact, transcellularly or paracellularly (Jang et al., 2004). Mucosal dendritic 
cells migrate through afferent lymphatics to the mesenteric lymph nodes, where they 
can present antigen in T-cell areas. So, the mesenteric lymph nodes are important for 
initiation or expansion of mucosal immune responses (Mowat, 2003).  
2. Antigen may be taken up directly to the Payer’s patches mediated by specialised M-
cells or paracellularly by dendritic cells. Migration of this cells to the T-cell zones results 
in T-cell activation, migration and induction of responses in the follicle of the Payer’s 
patch. Primed T- and B-cells emigrate from the patches in efferent lymphatics 
(Brandtzaeg & Pabst, 2004).  
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3. Intact antigen absorbed across the mucosal epithelium may reach the lymphatics 
directly and be transported to the lymph nodes and into blood, where it can interact 
with components of the systemic immune system (Telemo el al., 1991). 
4. Antigens may cross the enterocytes epithelial membrane in the form of exosomes. Pig 
enterocytes do not express MHC II proteins on their surfaces, but capillary lymphoid 
tissue epithelium in the pig’s intestine expresses high levels of MHC II molecules, so it 
could be possible that these cells release exosomes directly into blood (Wilson et al., 
1996). 
The diffuse lymphoid tissues 
Different cells and molecules are present into mucus membrane of the pigs’ gastrointestinal 
tract.  
1. Intestinal epithelium contains some amount of leucocytes. The predominant 
lymphocyte population express the CD8 coreceptors, unconventional subset of T-cells 
expressing a CD8ǂǂ homodimer and the TCR chains (Hayday et al., 2001). The majority 
of lymphocytes in the intestinal epithelium express CD2. A high proportion of 
lymphocytes express CD8+ in adults which do not appear in piglets until 7 weeks 
onwards (Whary et al., 1995). In young pigs, intestinal epithelium lymphocytes are 
mostly CD2-CD4-CD8-, and during the first few weeks of life CD2+CD4-CD8- appear. 
2. Lamina propria underneath the epithelium is well supplied with leukocytes and in pigs 
shows a high level of organisation (Wilson et al., 1996). Theirs’ APCs expressing MHC 
II protein class. Immature dendritic cells are present in large numbers within the villi 
and co-localise with T-cells expressing the CD4 coreceptor in the pig, but expressing the 
low affinity FcǄRIII (Bailey & Haverson, 2006). The point is that diffuse mucosal tissue 
has the first role in immune regulation, rather than active defensive responses. At the 
same time, these plastic cells may easiliy be switched from regulatory to active 
responses (Mellman & Steinman, 2001). 
3. The endothelium of the capillary plexus beneath the epithelial basement membrane 
expresses MHC II molecules as good as dendritic cells. There are also dendritic cells 
within the villi and help to promote CD4 co-receptor with T-cells.  
4. Lamina propria around intestinal crypts consists of cells staning for immunoglobulin 
(IgA, presumably plasma cells) and myeloid lineage cells have more characteristic of 
macrophages and granulocytes (Vega-Lopez et al., 1993). Plasma cells are 
predominantly IgA+, IgM+ and some IgG+cells are present.  
2.2 The role of antigen presenting dendritic cells 
The role of population of dendritic cells (DCs) in the intestine and associated lymphoid 
tissues is of great interest because theirs influence in maintenance of tolerance towards the 
commensal microflora and in protection against pathogens. There are unique functional 
properties of populations of intestinal DC, as well as the type of signals that are necessary 
for them to mediate these functions. The intestine and GALT have network of cells with 
antigen-presenting function, including macrophages, DCs (CD11c) and plasmacytoid DCs 
(Smith et al., 2005; Iwasaki A, 2007). Various subpopulations of DCs are present in the 
organized lymphoid tissue of the intestine, Payer’s patches and mesenteric lymph nodes, 
through the small intestine and lamina propria (Johansson & Kelsall, 2005). Dendritic cells 
have a central role in the activation of resting T cells and the initiation of primary responses. 
DCs acquire antigen (Ag) in peripheral tissues and transport it to lymph nodes (LNs) for 
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presentation to lymphocytes (Banchereau & Steinman, 1998). DCs migrate constitutively 
from peripheral tissue when they have acquired foreign Ag, but also in the absence of any 
antigenic or inflammatory stimuli (Huang et al., 2000). However, DCs continually migrate 
from the intestine to mesenteric LNs in the absence of overt antigenic stimulation (Liu et al., 
1998). Plasmacytoid dendritic cells (pDC) recognize pathogen molecules, particularly viral, 
and play crucial roles in the inate defense and regulation of adaptive immune responses 
(Colonna et al., 2004). pDCs function primarily via TLRs and ligation of these receptors 
stimulates the secretion of large amounts of cytokines, particularly IFN (Asselin-Paturel & 
Trinchieri, 2005).  
Theirs functional properties vary according to their anatomical location. Activated DC from 
the Payer’s patches produce higher levels of interleukin 10 (IL-10), than splenic DC (Iwasaki 
& Kelsall, 1999). Naive CD4 T-cells activated by DC from the Payer’s patches produce 
higher levels of IL-4 and IL-10, indicative of a T helper (TH2) type phenotype, than those 
activated by splenic DC. Surface phenotypic analysis of CD11c1 DC populations revealed 
that Payer’s patches DCs expressed higher levels of major histocompatibility complex class 
II molecules, but similar levels of costimulatory molecules and adhesion molecules 
compared with splenic DCs. But, the level of IFN-g produced by T cells primed with spleen 
DCs was significantly higher than that produced by T cells primed with PP DCs. While 
presentation of antigen by DCs in vitro leads to T cell activation, the same may not apply in 
vivo, and there is circumstantial evidence that DCs may be able to present Ag in a 
tolerogenic manner (Finkelman et al., 1996, Viney et al., 1998).  
Activated pDCs secrete proinflammatory cytokines, change their morphology from a round 
cell to dendritic cell-like, up-regulate MHC and costimulatory molecules and become 
effective APCs. Human pDCs activated by CD40L or influenza virus can induce 
proliferation and polarization of T cells. Mature pDCs efficiently stimulate T cells and drive 
a potent TH1 polarization in vitro, which is mediated by the synergistic effect of interleukin 
12 and type I interferon. In vivo, mature pDCs are found in secondary lymphoid organs, 
where they represent the principal source of type I interferon during inflammation (Cella et 
al., 2000). Mice pDCs activated with virus have shown to activate naive CD8+ T cells and to 
promote and polarization of Ag-experienced unpolarized CD4+ T cells (Krug et al., 2003). 
pDCs have a role in tolerogenic responses, as they can induce development of anergic T cells 
or T cells with regulatory function in vitro (Moseman et al., 2004). It is known now that 
depletion of pDCs can lead to airway hyperactivity to normally inert inhaled Ags, and that 
adoptive transfer of Ag-loaded pDCs before sensitization could prevent the induced asthma 
(De Heer et al., 2004). In this case Ag bearing pDCs was isolated from lung and the draining 
LN which suggested that similarly to classical DC, pDCs may acquire Ag at mucosal sites 
and transport it to the induce tolerogenic responses. There was no evidence for migration 
pDC in afferent lymph under steady state condition. However, Yrlid et al., (2006) showed 
that pDCs are not present in afferent lymph draining another mucosal tissue, especially the 
intestine. It is possible that the absence of pDCs in intestinal lymph is only in steady-state 
condition. These experiments suggest that pDCs present in mucosal tissues and liver do not 
induce tolerogenic or immunogenic Ag-specific T cell responses by acquiring Ag in the 
periphery and transporting it via afferent lymph to the draining lymph node. The 
mechanisms of acquiring Ag from periphery is unknown, potential mechanisms include 
delivery by classical DCs or exosomes or release of DC fragments (Villadangos & Heath, 
2005).  
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Dendritic cells in human are classified according to their cell-surface receptor expression 
into several subsets. In the Payer’s patches, conventional DCs are CD11chiCD11b+CD8ǂ-, 
CD11chiCD11b-CD8ǂ- and CD11chiCD11b-CD8ǂ+ subtypes, with unique anatomical 
localisation and functional properties. These DC can also be described in terms of their 
expression of the chemokine receptors CX3C chemokine receptor 1 (CX3CR1) and CC 
chemokine receptor 6 (CCR6, Salazar-Gonzalez et al., 2006). CX3CR1+ DCs were found to be 
associated with the follicle-associated epithelium in the steady state, whereas CCR6+ was 
recruited from the subepithelial dome to the follicle-associated epithelium during infection 
(Salazar-Gonzalez et al., 2006). An additional population of CD11cmid plasmacytoid DCs 
are present in the Payer’s patches and MLN, but they do not migrate from the intestine to 
the MLN (Yrlid et al., 2006). Similar subset composition we can find in the small intestinal 
lamina propria DCs. DCs in the small-intestinal lamina propria were found to express 
CX3CR1 (Niess et al., 2005). In the colon, DCs appear to be concentrated within isolated 
lymphoid follicles, with very few present in the lamina propria under steady-state 
conditions. MLNs contain population of DCs written before, but they are both migratory 
DCs arriving from the intestinal lamina propria in the steady-state and resident DCs that 
have developed from blood-home precursors. Functional differences depend on 
developmental origins, local environmental conditions and maturation states (Coombes & 
Powrie, 2008). CD11b+ DCs can be found in the subepithelial dome of the Payer’s patches, 
whereas CD8ǂ+ is present in the inter-follicular region. While 0CD11b+ DCs from the 
Payer’s patches produce IL-10 and prime Th2 cells, CD8ǂ+ and CD11b-CD8ǂ- were shown to 
produce IL-12 and interferon-Ǆ (IFN-Ǆ) by T-cells. Jejunal lamina propria in pigs contains 
large number of MHC class II cells, which could be divided into at least three subsets based 
upon expression of other markers. The majority of MHC class II co-expressed on CD45+ 
cells, and second population of cells expressing CD16, SwC3 and CD45. Actually, there are 
CD45+ and CD45- cells which very differ morphologically. The CD45+ cells are large, 
strongly adherent and had bilobed nuclei. The CD- is smaller and elongated with dense oval 
nuclei (Stokes & Bailey, 2000). Haverson & Riffault (2006) found that CD45+ population was 
potent stimulators of primary responses, but CD45- stromal population were unable to 
generate any proliferative response. Further, there are identified some unusual APC DC 
such as expressing both CD11c and MHC II at low intensity. These DC produced immune-
regulatory cytokines such as IL-10 and type I IFN, suggesting a role in immunoregulation 
and tolerance induction. These intestinal DCs are capable of presenting antigen and induce 
tolerance, but also can response to inflammatory stimuli to allow T cell priming and 
protective immunity (Mowat, 2005). 
DCs are separate lineage that is present in the steady state, but they have ability to run pro-
inflammatory responses. Alternatively, these cells may represent population of DCs in 
steady state but becomes more dominant during inflammation (Coombes & Powrie, 2008). 
Intestinal macrophages display some characteristics compared with splenic macrophages or 
those that derive from blood monocytes (Smythies et al., 2005). Human intestinal 
macrophages retain phagocytic and bactericidal activity, but they lack CD14 expression, 
which is obligatory for the Toll-like receptor 4 (TLR4)-mediated recognition of ligands. 
These cells showed an impaired ability to produce proinflammatory cytokines. These 
modifications might contribute to intestinal immune homeostasis by ensuring the contact of 
intestinal APCs with microbial products do not result in the generation of potentially 
destructive inflammatory responses.  
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2.3 Intraepithelial and lamina propria lymphocytes (IEL, LPL) 
Different antigens enter the body from the intestine: food proteins, commensal gut flora, 
invading pathogens, toxins. The digestive tube is lined by a continuous monolayer of 
epithelial cells. That intestinal epithelial cells (IEC) act as a physical barrier, separating the 
contents of a luminal environment from the layers of tissue comprising the interior milieu 
(Gewirtz et al., 2002). IEC also participate in the innate immune response of the intestine like 
a physical barrier, mucus secretion, antibacterial peptide synthesis and participation in the 
cytokine/chemokine network (Oswald, 2006).  
2.3.1 Intraepithelial Lymphocytes (IEL) 
At the basolateral surfaces of intestinal epithelial cells there are intestinal intraepithelial 
lymphocytes (IEL) which play important roles in the homeostasis of intestinal 
microenvironment. Intraepithelial lymphocytes (IEL) are predominantly T lymphocytes, a 
major subpopulation of Ǆǅ i-IEL is produced from uncommitted precursors at extrathymic 
sites (Bandeira et al., 1991; Poussier & Julius, 1994). T cells appear to have both 
proinflammatory and regulatory functions: they can act as a bridge between innate and 
adaptive immunity early in responses and can down-modulate inflammatory responses 
(Newton et al., 2006). 
In samples of proximal and distal small intestine of five 6-month-old pigs (Vega-Lopez et al., 
1995) were studied CD2, CD4 (helper/inducer T-cells), CD8 (suppressor/cytotoxic T cells), 
accessory cell marker (monocyte/granulocyte) and MHC Class II (DRw) receptor. CD2+ 
cells were found in high numbers in both the epithelium and the lamina propria. Two 
subpopulations of intraepithelial lymphocytes were identified: apically in the epithelium 
there were CD2+CD4-CD8-(double negative) cells, whereas cells expressing CD8 marker 
were concentrated around the basement membrane. CD4+cells were localized in the lamina 
propria towards the villus core. Accessory cells were distributed in crypts and the villus 
base and more cells were found in ileum than in duodenum. In contrast, MHC Class II+ cells 
were located predominantly in villi, just underneath the basement membrane, forming a 
sheath of cells between the CD8+ and the CD4+ cells. Pig IEL express CD2 and have an 
increased proportion of CD8+ cells (Stokes et al., 2001; Davis et al., 2004). However, neonatal 
pigs are mostly CD2−CD4−CD8−, and CD8+ IEL cannot be recognized until the animal 
matures. Bailey et al. (2001) confirmed the infiltration of CD8+ T cells within the intestinal 
lamina propria of the villi from 4 week of age onward. It has also been demonstrated that 
phenotypic changes in porcine IEL are influenced by exposure to environmental antigens 
(Pabst & Rothkotter, 1999, Bailey et al., 2005). McCracken et al. (1999) reported that the 
number of CD8+ T lymphocytes per 100 m of villus isolated from the intestinal jejunum was 
increased post weaning. 
According to morphology, size, and sedimentation density of lymphocytes, Hayday et al., 
(2001) have proposed that IEL be classified into 2 subgroups: Type a and Type b. As Type a 
IEL would be included intraepithelial lymphocytes that are thymus-dependent, activated 
within the peripheral circulation, that express the ǂǃ T-cell receptor, and that recognize 
antigen in the context of major histocompatibility complex I or II. Type b IEL are thymus-
independent cells that express T-cell receptors that are Ǆǅ+, Ǆǅ+CD8ǂǂ+, or ǂǃ+CD8ǂǂ+. Both 
types of IEL are cytolytic effectors that secrete cytokine and chemokine mediators. Havran et 
al. (2005) supported the idea that intraepithelial Ǆǅ+ T cells are involved in tissue repair, lysis 
of damaged epithelial cells, and inflammatory cell recruitment (qualified like innate 
immune response), while type a IEL are more indicative of an adaptive response. Egan et al 
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(2011) showed that ǂǃ and not Ǆǅ T-cell IELs mediate intestinal damage in mice after 
parasite infection. In that case IELs did not function alone to cause inflammatory lesions, but 
acted with CD4+ T lymphocytes from the lamina propria (LP). IEL has ability to bind to E 
cadherin on IEC, which is facilitated by the expression of ǂEǃ7 integrin (Cepek et al., 1994). 
Zuckermann and Gaskins (1996) reported that mucosa-associated lymphoid tissues had 
significantly smaller proportions of CD4+ and/or CD8+ T cells than lymph nodes and 
CD4/CD8 double positive cells accounted for a larger proportion of the total CD4+ 
lymphocytes than in lymph nodes. The mid-section of the continuous Peyer’s patch in the 
ileum contained 7% CD4 single positive, 8% CD8 single positive and 4% CD4/CD8 double 
positive lymphocytes. 
2.3.2 Lamina Propria Lymphocytes (LPL) 
The gastrointestinal lamina propria is composed of smooth muscle cells, fibroblasts, blood 
vessels and lymphatics that make up a highly vascular layer of loose connective tissue 
underlying and supporting the mucosal epithelium. There are macrophages, dendritic cells, 
neutrophils, mast cells, and lymphocytes that participate in lamina propria effector 
functions (Hunyady et al., 2000). The population of lymphocytes that resides in the lamina 
propria has been classified as heterogeneous, and the organization of these cells is classified 
as random (Bailey et al., 2005). These characteristics are consistent with the effector function 
of lamina propria lymphocytes, which enables these cells to participate in 
immunosurveillance and to respond actively to potential pathogens (Burkey et al., 2009). 
Mixed population of T lymphocytes include helper CD4+ in adult swine settled in lamina 
propria of the villi and suppressor/cytotoxic CD8+ lymphocytes closer to epithelial cells 
(Vega-Lopez et al., 1993). The same author found that lamina propria comprise the unique 
population of CD2+CD4+CD8+ lymphocytes (about 30%), as well as CD2+ and SWC3+ (swine 
workshop cluster) monocyte-granulocyte cells. Important differences in lamina propria 
lymphocytes exist between humans and swine that may relate to the function of these 
compartmentalized cells. In the small intestine of pigs, lymphocytes have been categorized 
as diffuse or organized (Pabst & Rothkotter, 1999). For the most species, intraepithelial 
lymphocytes and lymphocytes contained in the lamina propria are considered diffuse 
lymphocytes. In contrast, the gut mucosa of the pig has a greater degree of organization 
compared with the gut mucosa of rodents and humans (Bailey et al., 2001). For example, 
Vega-Lopez et al. (1993) observed that plasma cells are preferentially localized to the 
intestinal crypts and T cells to the intestinal villi. The same authors also observed a spatial 
separation between CD4+ and CD8+ T cells within the lamina propria of intestinal villi. In 
addition, researchers have observed differences in cytokines secreted by activated porcine 
and murine lamina propria T lymphocytes compared with human lamina propria T 
lymphocytes (Harriman et al., 1992; Bailey et al., 1994). The significance of the differences 
that exist in pigs has not been fully elucidated. It has been suggested that lamina propria 
lymphocytes, in addition to their effector function, also have a role in immunoregulation 
(Bailey et al., 2001). Lamina propria T cells differ from peripheral T cells in that they have a 
greater threshold of activation, produce increased concentrations of cytokines on stimulation, 
and have a phenotype associated with immunologic memory (Wittig & Zeitz, 2003). 
2.4 Gut cytokines 
Cytokines are small peptide molecules derived either from traditionally immune cells 
(lymphocytes, macrophages) or produced by epithelial cells, endothelial cells and fibroblasts 
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(Pie et al., 2003). They are powerful mediators that regulate the appropriate host defence 
against enteric pathogens and other luminal events, and participate in the maintenance of 
tissue integrity. Cytokines receptors are located on both immune and non-immune cells, and 
every change in the number, location and distribution of these receptors exert a significant 
impact on the function of the gut. Syntesis of proinflammatory cytokines can have a strong 
influence on gut integrity and epithelial functions, permeability to macromolecules and 
transport of nutrients and ions (McKay & Baird, 1999).  
The usefulness of gut immunity depends on tissue integrity, cell function, clinical states, the 
site of primed immune or others cells. Production of cytokines depends also on mucosal 
micropopulation. Daudelin et al. (2011) found that expression of IL-8 in the ileum was 
significantly greater in the pigs challenged with ETEC F4 than in the nonchallenged animals, 
but IL-8 gene expression was significantly increased with probiotic addition (P. acidilactici + 
S. cerevisiae boulardii), compared to the control group. Other in vitro studies indicate an 
increase in IL-8 production following the stimulation of porcine intestinal epithelial cells, 
Caco-2 cells or a porcine macrophage cell line (3D4/31) with ETEC F4 (Roselli et al, 2006; 
Pavlova et al., 2008). Probiotic bacteria such as Bifidobacterium lactis BB12 stimulated IL-6 
production in primary murine intestinal epithelial cells (Ruiz et al., 2005). In addition, this 
cytokine plays an important role in the regulation of immune intestinal response, barrier 
fortification, activation of neutrophils and B cell IgA isotype switching (Haller et al., 2000). 
Similarly, ileal TNF-a gene expression tended to be upregulated in the P. acidilactici + S. 
cerevisiae boulardii group in comparison with the control group, which means that the 
administration of probiotics induced a stronger inflammatory reaction than the feeding of 
an antibiotic enriched diet (Daudelin et al., 2011). The pattern of cytokine secretion by pig 
intestinal epithelium depend on the strain of bacteria used (Bailey, 2009). In study by Roselli 
et al., (2007), Lactobacillus sobrius reduced the amount of IL-8 secreted by IPEC-1 in response 
to ETEC, by stimulation of IL-10 secretion.  
There are many reported studies in which feed supplements enhance a component of the 
immune system. Rodrigues et al.,  (2007) reported that viable probiotics are more efficient 
than inactivated probiotics to induce immunostimulation and intestinal modifications in 
piglets, thus improving their health and development. More IgA expressing cells were 
found in the mesenteric lymph nodes with the probiotic with viable cells than observed in 
the inactivated cells treatment. It should be very careful in comparisons and judgments in 
regard of specific probiotic/prebiotic strains, environment conditions, animal’s age and feed 
composition. Nutrition can also modulate the intestinal cytokine level. Wu et al., (1999) 
found marked decrease in the levels of IL-10 and IL-4 in mice avoiding enteral feeding.  
The roles of gut epithelium are regulation of tissue permeability, absorption of nutrients and 
ions, secretion and contraction of smooth muscle necessary for mixing contents. Following 
antigen stimulation, naive CD4+ T cells proliferate and differentiate into various T cell 
subsets including T helper (Th)1, Th2 and Th17 effectors cells, and T regulatory cells-Treg 
(Vignali et al., 2008). The development of Th1 cells is the typical response to intracellular 
pathogens, such as bacteria or viruses. Th1 cells mediate through their secreted cytokines: 
interferon gamma (IFN-Ǆ), tumor necrosis factor alpha (TNF-ǂ), IL-1ǃ, IL-2, IL-12. Th2 cells 
are initiated by IL-4 and develop in response to allergens or parasite infection. Cytokines 
that induce Th2 cells are IL-4, IL-5, IL-13. The third T-effector cell lineage is Th17 subset, 
which also participate in antimicrobial immunity and inflammatory pathology (Bailey, 
2009). Commensal microbial flora drives accumulation of Th17 T cells in healthy, SPF 
compared to germ-free mice, but numbers and activation state further increase in colitis 
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(Niess et al., 2008). The differentiation of CD4+ T cells into Trag plays a critical role in 
maintaining immunological tolerance to self antigen or suppressing excessive immune 
responses (Vignali et al., 2008). Mucosally activated T cells may differ from systemic T cells 
better towards interleukin-4 (IL-4) than IL-2, by polyclonal lines from murine lamina 
propria cells (Bailey et al., 1994). Some cytokines expressed by the intestinal epithelium and 
have great influence on the epithelial cells growth and homeostasis are TGF-ǃ, IL-1ǂ, IL-6. 
IL-8, IL-1ǃ and TNF-ǂ upregulated in response to microbial infection. After an ischemic or 
ischemia/reperfusion type injuries the levels of TNF-ǂ and IL-6 released from the rats’ gut 
(Grotz et al, 1999). The recent study suggests that gut microflora may have adverse effects 
by modulating gut cytokines, which would alter other components of gut function, and may 
make the host susceptible to other infectious and metabolic processes. The portal and 
systemic TNF and IL-6 levels were higher in those rats whose GI tracts were colonized with 
E. coli (bacterial overgrowth) than in rats with either normal intestinal microflora or whose 
intestinal flora had been decontaminated with oral antibiotics. The disruption of the normal 
intestinal microflora may result in bacterial overgrowth with enteric bacilli that can 
subsequently translocate to distant organs and the systemic circulation.  
3. Natural products and biological substances as immune response 
modifiers 
Since 2006 the European-wide directives are restricting the non-clinical use of antibiotic 
growth promoters (AGPs) in food animal production. To accommodate the withdrawal of 
AGPs it now becomes urgent to provide relevant health criteria and scientifically founded 
recommendations for alternatives to in-feed antibiotics. Since the 1980's intriguing reports 
have appeared suggesting that vast variety of substances of natural origin can restore, 
stimulate or suppress nonspecific and specific immunity in domestic food animals and, 
hence improve their growth and performance, acting as immune response modifiers (IRMs).  
The scope of this chapter is to compile recent knowledge on the exogenous 
immunomodulation of the immune responses in the pig as an important biomedical model. 
With the growing knowledge of porcine immune system and its endogenous modulation, it 
has been clarified that exogenous immunomodulation represents an important 
prophylactic/therapeutic approach aiming at stimulating natural host defenses through the 
use of a broad spectrum of immunomodulating/growth-promoting agents of a natural 
origin generally termed IRMs. With combined efforts of basic and clinical veterinary 
immunologists, animal producers and feed manufacturers, immunomodulation will bring 
into veterinary medicine, particularly in swine production, the same type of curative 
revolution as antibiotics have in the combat against infectious diseases. However, it is 
essential to select fully evaluated IRMs which may act either as nonspecific 
immunostimulators or synergistically as adjuvants with vaccines. Although, numerous of 
these substances have been successfully used in in vivo nutritional investigations in pig, 
substantiation of their efficacy is still lacking. Herein we will comparatively analyze 
immunomodulating properties of some IRMs such as prebiotics, probiotics and 
immunomodulators (including microbiotics, fungibiotics, phytobiotics and zoobiotics) 
from several sources applied in vivo in different concentrations using domestic swine as a 
model organism in relation to immunostimulatory effects of some exogenous IRMs of 
microbial or animal origin tested in vitro and in vivo on suckling and weaned pigs in our 
laboratory. 
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3.1 Early days of IRMs 
Since the mid 1980's intriguing reports have appeared suggesting that vast variety of 
substances of natural or synthetic origin act as IRMs and can restore, stimulate or suppress 
the innate and adaptive immunity in domestic food animals and, hence improve their 
growth and performance (Blecha and Charley, 1990). The enormous number of empirical 
studies of exogenous effects of manipulation of the immune system of the pig by IRMs and 
feed additives have been carried out (reviewed by Valpotić, 2000; Gallois et al., 2009; Bailey, 
2009).  
The naturally occurring substances with a long history as immunomodulators are the herb 
extracts described by Chinese traditional medicine originated from plants Angelica sinensis 
and Cynachus auriculatus, which are well known today as IRMs (Weng et al., 1987) or 
antimicrobials (Kawakita et al., 1987). Today is possible to extract, characterize and classify 
the substances with putative immunomodulatory properties from different natural sources. 
Based on their biological or chemical origin bioactive substances with properties of IRMs 
have been classified by Poli (1984). Further, Reizenstein & Mathe (1984) divided IRMs on the 
basis of their origin to biological and synthetic substances. Moreover, a number of 
chemotherapeutics exhibited immunomodulatory activities (Sedlacek et al., 1986). The IRMs 
of importance for veterinary medicine were further classified into three categories as: 
physiological products, microbial products and synthetic compounds (Mulcahy & Quinn, 
1986). Generally, the IRMs may be divided into substances of endogenous origin, normally 
produced by the genome of the host and those of exogenous origin which are not products 
of mammalian genome, but may stimulate production of endogenous IRMs and modulate 
the immune response of the host (Roth, 1988). The capacity of tested endogenous 
(neuropeptides, hormones, cytokines, immunoglobulins, peptides) and exogenous IRMs (plant 
and microbial extracts, synthetic compounds, feed additives, drugs) to improve immune status 
of laboratory and domestic animal species has been thoroughly reviewed (Wybran, 1988; 
Georgiev, 1991, 1993; Valpotić, 2000). The synthesis of all these classifications, supplemented 
with newly emerged bioactive organisms/substances is given in the Table 1.  
 
Origin 
of IRMs 
Type of 
immunomodulation
Group/source of IRMs Bioactive molecules/organisms 
E
N
D
O
G
E
N
O
U
S 
Physiological - hormones 
- cytokines  
- acute phase proteins 
- enzymes 
- nucleic acids 
thymic hormones, lymphokins, 
monokins, inteferons, TNFǂ/ǃ, CSF, 
CRP, haptoglobin, neopterins, NOS, 
immunogenic RNA/DNA  
Neuroendocrine - hormones 
- neuropeptides 
ACTH, glucocorticoids, 
somatostatin, prolactin, TSH, 
opioids (enkephalin, endorfin, 
dinorfin, neurotensin) 
Behavioral - brain-immune system
- interactions 
neurotrasmitters (VIP, SP), 
cytokines (IL-1, TNFǂ, IL6, IL-8), 
hormones (ACTH, ǃ–endorfin, 
thyreotropin, cortisol) 
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Origin 
of IRMs 
Type of 
immunomodulation
Group/source of IRMs Bioactive molecules/organisms 
E
X
O
G
E
N
O
U
S 
Biological - microbiotics 
- fungibiotics 
- phytobiotics  
- zoobiotics and their 
products/by-
products/derivatives
viruses (Duphamun® – inactivated 
avipox virus, Baypamun®- 
inactivated Parapoxvirus ovis), 
bacteria (P. acnes, E. coli, M. bovis, S. 
pyogenes, L. casei, S. olivoreticuli, K. 
pneumoniae), yeasts (S. cerevisiae) and 
their derivatives (mannan, glucan), 
fungi (T. inflatum, L. edodes, C. 
albicans, A. bisporus) and their 
derivatives (mannan, glucan, 
lentinan) , plant and algal extracts 
(carotenoids, flavonoids,  
polyphenols, saponin, fucan, 
carvacol, thymol, curcumin, 
laminarin, phycarin, fucoidan), 
animal products (bee venom, royal 
gelly, propolis, fish oil) and animal 
by-products (colostrum, lactoferrin, 
spray-dried plasma, purified IgG or 
total Igs)   
Chemical  - natural compounds 
- synthetic compounds 
- metals/microelements
lipopolysaccharide, peptidoglycan, 
muramil dipeptide, levamisole, POE-
POP copolymer, isoprinisine, 
indometacine, ascorbic acid 
derivatives, ciprofloxacin, 132Ge 
organic compounds, organic acids 
(acetic, benzoic, citric, formic, 
fumaric, lactic, phosphoric, 
propionic, sorbic, tartaric), acetic salts 
(K/Na-benzoate, Na-
butyrate/citrate, K-formate/sorbate, 
Ca-lactate/propionate), Zn, Fe, Cu, Se. 
Nutritive - nutrients 
- nutraceuticals 
nucleotides, aminoacids (arginine, 
cysteine, glutamine),carotenoids, 
flavonoids, n-3 , polyunsaturated 
fatty acids, vitamins (A and E),  
minerals (Zn, zeolites)  
Table 1. Classification of IRMs based on genetic origin, group/source and type of 
immunomodulation 
TNF = tumor necrosis factor; CSF = colony-stimulating factor; CRP = C-reactive protein; NOS = 
nitricoxide synthase; ACTH = adrenocorticotropic hormone; TSH = thyroid stimulating hormone; VIP = 
vasoactive intestinal peptide; SP = substance P; IgG = immunoglobulin G; POE-POP = polyoxiethylene 
polyoxipropylene 
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The most common protocol for studies of IRMs effectiveness involves feeding (or 
application via other routes) the test bioactive substance or compound to young animals, 
recording feed intake and growth rate as a measures of the efficiency of the animal overall, 
and recording immunological parameters as direct measures of contribution of the IRMs 
effect on immunological function. The results from such studies generally fall into two 
categories. In the first, application of IRMs resulted in an increase in a specific parameter of 
the immune system. Recently reported studies in which feed supplements enhance a 
component of porcine immune system have generally focused on increases in IgA, cytokines 
or serum/intestinal leukocyte subsets. In the second, feed supplementation had no effect or 
decreased measures of the mucosal immune system. A modification of this protocol is to 
challenge test and control pigs with a specific pathogen or antigen (including vaccines), 
where outcomes have been similarly variable (reviewed by Blecha & Charley, 1990; 
Valpotić, 2000, Gallois et al., 2009; Bailey, 2009). 
It should be apparent from the previous discussion regarding modulation of growth and 
immune functions that the observation of increased, decreased or unchanged measures of 
these parameters by themselves cannot be interpreted as beneficial or harmful. Each of the 
studies reports important finding, but an understanding of the mechanisms and, perhaps 
more importantly, the ability to predict which IRM or feed additive may be beneficial under 
particular environmental conditions, is going to require many more studies and an overall 
meta-analysis of the data. The advantage of working with the pig for these studies is that 
large field trials can be carried out under a range of environmental challenges (intensive, 
extensive rearing systems) in association with detailed study protocols comprising defined 
and well characterized IRMs. 
Following a brief description of historical aspects on IRMs, we will focus on a group of 
exogenous bioactive organisms/substances that have been suggested to show 
immunomodulatory properties, particularly in the pig model systems.  
3.2 Nonspecific immunomodulation in swine: A state of art  
Unlike specific immunmodulation or vaccination, nonspecific immunmodulation is a 
complex concept in scientific terms because there is the necessity to balance 
immunostimulation against excessive activation of the immune system which is usually 
damaging and growth-inhibiting. Also, certain IRMs when used as immunostimulants are 
likely to exhibit immunosuppressive effect at increased doses. Clearly a more robust, rapid 
and sustained immune response would be desirable. Pigs selected for high humoral and 
cellular immune responses had better growth rates than pigs with low immune responses 
(Wilkie & Mallard, 1999). In pig production, this is of particular importance during the 
weaning transition when pigs are subjected to major stressful events, making them highly 
susceptible to digestive disorders. At that time, the development of both innate and 
adaptive systemic and local intestinal immunity is critical in preventing the potential 
harmful effects of pathogenic agents. Strategies aiming at stimulating natural defenses of 
swine through the use of IRMs able to modulate immune functions have gained increased 
interest in animal research, and different bioactive components sharing properties of IRMs 
have been the subject of in vivo and/or in vitro investigations in pigs (Blecha & Charley, 
1990; Valpotić, 2000, Gallois & Oswald, 2008; Gallois et al., 2009).  
Nonspecific immunostimulation primarily implies stimulation of the innate or nonspecific 
immunity which comprises monocytes/macrophages, neutrophils, NK cells, intraepithelial 
lymphocytes, complement, CRP, haptoglobin and cytokines, such as IFNs, but also certain T- 
and B-lymphocyte subsets of adaptive or specific immunity. The aim of immunomodulating 
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substances is to help pigs develop “appropriate/optimal” active responses from both innate 
and adaptive immunity. However, these substances generally termed IRMs have to fulfill a 
variety of properties from technical and regulatory viewpoints, but also should share a 
positive image towards the public (Gallois et al., 2009). Thus, products/derivatives from 
natural sources will probably be easily accepted by the public and legislation.  
3.2.1 The effects of IRMs as natural alternatives to AGP in pig production  
Until recently, problems of enteric infections in food animal production have been overcome 
by adding sub-therapeutic doses of AGPs in-feed to enhance production efficiency in swine 
industry (Cromwell, 2002). Concerns about potential risks for human health due to use and 
misuse of AGPs in animal feeds (Dewey et al., 1997) have led to their ban throughout EU 
(Regulation EC no. 1831/2003). These criteria which are commonly accepted within EU 
must be usable for objective assessment of alternatives to in-feed AGPs (Gallois et al., 2009) 
and must be acceptable for swine producers, feed manufacturers and consumers. To 
accommodate to withdrawal of AGPs it now becomes urgent to provide relevant gut health 
criteria for a large-scale production of pigs and scientifically founded recommendations for 
alternatives to in-feed AGPs. More recently focus has shifted from specific immunization to 
another non-antibiotic approach offered by the use of IRMs, and prebiotics/probiotics in 
non-specific immune/nutritive stimulation of resistance to enteric infections. Such strategies 
aiming at stimulating natural host defence through the use of substances of natural or 
synthetic origin able to modulate immune functions have gained increasing interest in food 
animal research (Mulcahy & Quinn, 1986; Blecha & Charley, 1990; Valpotić, 2000; Gallois & 
Oswald, 2008; Gallois et al., 2009). This chapter will focus on groups of in-feed alternatives 
to AGPs originated from fungi and their derivatives, termed fungibiotics (Table 2), plants 
and their extracts, termed phytobiotics (Table 3) and animal products and by-products, 
termed zoobiotics (Table 4) that have been suggested to exhibit immunomodulatory 
properties and that have been tested in in vivo studies in pigs. 
A variety of polysaccharides from different natural sources, particularly yeast derivatives ǃ-
D-glucans and ǂ-D-mannans (Brown & Gordon, 2003) have been recognized to be 
responsible for modulating the immune responses in farm animals, including pigs (Table 2) 
through specific interactions with different immune cells (Kogan & Kocher, 2007). 
Numerous preparations derived from yeast cell walls, fungi (Table 2), marine algae or 
plants (Table 3), particularly rich in glucans and mannans, have been investigated in pigs. 
The BGC extracted from the cell wall of baker’s yeast Saccharomyces cerevisiae is the most 
common source used for pig in-feed complements. It is a ǃ-1,3-glucan with long ǃ-1,6-
glucan branches, whose structure is different from the ǃ-glucans extracted from bacteria 
(linear ǃ-1,3-glucans), fungi (short ǃ-1,6-glucans branched ǃ-1,3-glucans) and cereals (ǃ-
1,3/1,4-glucans), and thus, their different chemical structures would be expected to be 
reflected in their different bioactivities (Tzianabos, 2000). Much interest has been paid to the 
effects of BGC and MOS on porcine systemic immune responses, particularly innate 
immunity, whereas literature dealing with their effects on local intestinal immunity is very 
scarce (Table 2). Generally, the effects of BGC on porcine immunity are not predictable and 
their ability to act as growth-promoters is also not reliable. Their beneficial effects on health 
were difficult to detect since many of the studies have been performed in “clean” 
environments where morbidity/mortality rates are low. As for BGC, the influence of MOS 
on porcine immunity is not always reliable, as well as their effects on pigs performances and 
health, particularly following challenge infections with enteric pathogens (Table 2). 
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Stressor/challenge or 
vaccinal organism 
IRM applied in-feed or 
per os  
Effects on immune and production parameters
Weaning β-glucan polysaccharide 
(BGC; single oral dose of 
100μg or 1mg/pig)  
NT; 
Increased average body weight 
Weaning  BGC (0.1% ) None on blood neutrophil function; 
Lower average daily feed intake; 
None on average body weight. 
Weaning 
/Streptoccocus suis - 
immunization 
BGC (0.025-0.05%) None on phagocytic function of macrphages/neutrop
Decreased level of haptoglobin in plasma; 
Increase of average body weight; 
Higher average daily feed intake.  
None on feed conversion. 
E.coli vaccine/Partus BGC (0.05%)  Increased levels of specific colostral/milk antibodies; 
None on no. of liveborn/stillborn pigs; 
Decreased average body weight; 
Slower recovery from neonatal diarrheal disease. 
Weaning  BGC (0.05%) Decreased serum level of antibody to F6 antigen or with
influence on antibodies to F4, F5 and LT antigens; 
Increased average body weight; 
Without influence on incidence of diarrhea. 
Weaning BGC (0.4%) 
 
Increased proportion of CD8+ and decreased proportion of
CD4+ T cells;  
Decreased no. of granulocytes/monocytes; 
None on average body weight and average daily feed
Decreased incidence of diarrhea. 
Weaning α-mannan oligosaccharide 
(MOS; 0.1%) 
None on blood proportions of CD4+ or CD8+ cells. 
Weaning MOS (0.2%) Without influence on proliferative response of PBL. 
Weaning/F4+ E. coli 
challenge 
MOS (3%) from brewer’s 
yeast) 
None on serum levels of IgA, IgM and IgG following 
challenge or without challenge.  
w
w
w
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Stressor/challenge or 
vaccinal organism 
IRM applied in-feed or 
per os  
Effects on immune and production parameters
Weaning/ 
Salmonella enterica - 
challenge 
MOS (0.15%)  Increased serum concentration of haptoglobin; 
None on serum level of Il-6; 
Without influence on hyperthermia after challenge i
None on growt performance.  
Weaning MOS (0.3%) Without influence on no. of intestinal macrophages;
Increased phagocytosis of macrophages from JLP.  
Lowered ratio of CD3+ CD4+/CD3+ CD8+ blood T ce
a higher proportion of CD8+ T cells.  
Decreased no. of blood neutrophils. 
Weaning  MOS (0.2- 0.3%) Decreased proliferative responses of PBL to PWM or
Weaning/PRRS virus - 
vaccination 
BGC (0.015-0.03%) Tendency of serum haptoglobin increase;  
None of lymphocyte proliferation; 
Without influence on increase in level of specific anti
PRRS virus; 
None on average body weight and feed conversion; 
Increased average daily feed intake. 
Weaning/ 
Ovoalbumin - or LPS - 
immunization + LPS 
in vitro 
BGC (0.005%) Short-term increase of humoral immunity to ovoalbum
Increased release of IL-10, and decreased IL-6 and TNFα 
production after in vitro or in vivo stimulation of PBL w
NT. 
Weaning/LPS - 
immunization 
BGC (0.005%) Increased plasma levels of IL-6, TNFα and IL-10; 
Without influence on somatotropin level. 
Weaning BGC (0.005%) Decreased reactivity of PBL to PHA or ConA mitogens
Increased average daily feed intake and body weight: 
None on feed conversion. 
Weaning/Atrophici 
rhinitis – vaccination 
+ in-feed antibiotics 
BGC (0.02-0.04%)  Slightly changed level of antibody specific for Pasteurella 
multocida sv. A and D;  
Increased proportion of CD4+ and tendency of increase
proportion of CD8+ PBL; 
Increased average body weight; 
Better feed digestibility. 
w
w
w
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Stressor/challenge or 
vaccinal organism 
IRM applied in-
feed or per os  
Effects on immune and production p
Weaning/LPS -
immunization  
BGC (2.5%) Increased intestinal TNFα and IL-1β, but
receptor antagonist mRNA;  
None in blood TNFα level and leukocyte 
Weaning MOS (0.1%)  Reduced recruitment of lymphocytes int
lamina propria; 
Profiles of intestinal and PBL subsets infl
Weaning/F4+ ETEC - 
immunization 
BGC (0.05%); from 
fungus Sclerotium 
rolfsii)  
 
Decreased serum level of antibody to F4
Increased numbers of IgM+ and IgA+ plasma c
JPP/IPP, and  decreased in MLN;  
Lower susceptibility for F4+ ETEC infection;  
Lower incidence of fecal isolates of F4+
Milder or totally reduced diarrhea. 
Weaning/ 
S. enterica sv. 
Typhimurium - 
immunization 
BGC (0.2%) NT;  
None on average body weight; 
Lower incidence of S.enterica sv. Typhimuri
feces: 
Weaning/F4+ ETEC - 
immunization 
Yeast fermentation 
product (0.2% 
XPC®) from S. 
cerevisiae) 
Increased PCV of blood leukocytes; 
Increased average daily feed intake, 
Smaller no. of adherent ETEC to ileal m
Decreased no. of Eneterobacteria in ileal c
Improved growth and gut health status
w
w
w
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Stressor/challenge or 
vaccinal organism 
IRM applied in-feed 
or per os 
Effects on immune and production parameters 
Weaning*/ S. enterica 
sv. Typhimurium - 
immunization 
Fucan polysaccharide 
(0.5-2.0%) from seaweed 
Ascophillum nodosum) 
Increased feed intake, but decreased feed efficiency; 
Without influence on immune responses; 
Challenge infection had only moderate effects on pigs; 
Increased activation of alveolar macrophages to secrete 
prostaglandin E2 (PGE2); 
None on secretion of IL-10 by splenocytes.  
Weaning/ S. enterica 
sv. Typhimurium - 
immunization 
Saponin (0.0125-0.05%) 
from Quillaja saponaria) 
Without influence on feed intake and growth rate follow
challenge infection with S. enterica; 
None o serum levels of haptoglobin, α-1-acid glycoprotein 
postinfection; 
Slightly weaker phagocytic function of blood leukocytes 
higher dose of saponin. 
Weaning Saponin/Curcumin 
(0.02-0.03%) from Q. 
saponaria/Curcuma longa) 
Without influence on immune response (curcumin);  
Increased concentrations of IgA, IgG and CRP (saponin); 
Decreased feed : weight gain ratio and, thus, feed utilization; 
Improved health status of pigs.  
Weaning Carvacol, thymol (0.3%) 
from Cinnamomum spp., 
Capsicum annum and 
Oregano feed 
additive™) 
Increased proportions of CD4+, CD8+ and CD4+/ CD8+ T cells
peripheral blood and MLN 
Protection of low-weight pigs from disease. 
Weaning Sugar cane extract - 
polysaccharides ?) (0.5-
2.0g/kg of BW) from 
Saccharum officinarum 
Increased NK cell cytotoxicity and phagocytosis of 
monocytes/neutrophils; 
Low morbidity and mortality rates. 
Weaning Chicory acid, alkamids 
(1.8 cobs for 6 weeks) 
from Echinacea purpurea) 
None on growth performance; 
Slightly increased feed efficiency; 
Nonaffected blood parameters – cell count and proliferation of
Improved health status of pigs; 
w
w
w
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Stressor/challenge or 
vaccinal organism 
IRM applied in-feed 
or per os 
Effects on immune and production parameters 
Weaning/ 
Erysipelothrix 
rhusiopathiae - 
vaccination 
Chicory acid, alkamids 
(1.5 cobs and 4-6 ml 
juice/day for 9 weeks) 
from E. purpurea 
Enhanced response to vaccine against Erysipelothrix rhusiopathiae; 
Increased serum level of specific antibody. 
Weaning/LPS - 
immunization 
 
BGC (0.05-0.1%) from 
Chinese herb Astragalus 
membranaceus) 
Increased plasma levels of IL-1β, PGE2 and cortisol;  
Enhanced reactivity of PBL to ConA;  
Increased production of IL-2  following the immunization;.  
None on average body weight and feed conversion;   
Decreased average body weight after immunization with 
Increased average daily feed intake; 
Higher plasma level of glucose. 
Increaed plasma levels of IL-1β and PGE2 after LPS immunizati
Weaning/Ovoalbumin 
- immunization 
BGC (0.01-0.1%) from A. 
membranaceus)  
Incresed blood leukocyte count; 
Increased proportion of CD4+ T cells; 
Increased blood concentrations of IL-2  and IFNγ following
immunization; 
Non-affected levels of IL-4 and IL-10; 
None on specific antibody titers following immunization with 
ovoalbumin.  
Weaning Carvacol, 
cinnamaldehyde, 
capsicum oleoresin 
(0.03%) from Origanum 
spp.) 
None on subsets of mononuclear cells from IPP; 
Decreased percentage of B cells in ileal/colonic lymph nodes. 
Weaning Carvacol, thymol (0.05-
0.15%) from 
Phytogenic™ additive) 
Without influence on plasma levels of CRP and haptoglo
w
w
w
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Stressor/challenge or 
vaccinal organism 
IRM applied in-feed or 
per os 
Effects on immune and production parameters 
Weaning/LPS or 
Ovoalbumin- 
immunization 
Flavonoids, polyphenols 
(1%) from Bahzen™ 
Chinese herbal 
medicine) 
Increased blood leukocyte count; 
Enhanced release of serum IL-6 and TNFα following 
LPS immunization; 
Increased levels of blood IgG and activity of 
neutrophils; 
Without influence on specific antibody resp
SRBC or ovoalbumin; 
Improved growth rate. 
Weaning BGC (0.15%) from brown 
algae L. digitata and/or 
L. hyperborean) 
Increased expression of mRNA for IL-8; 
Increased no. of monocytes; 
Decreased no. of enterobacteria,  bifidobacteria
lactobacilli in colon/cecum;  
Lowered height of intestinal vili in 
duodenum/jejunum. 
Level of gases in 
fattening unit 
BGC (?) from barley and 
oats – diets (13.5MJ/kg) 
with either or with their 
combination  
NT;  
Lower digestibility of feed;  
Increased no. of Bifidobacterium spp. and Lactobai
in colon; 
Decreased concentration of ammonia. 
Weaning/LPS- 
immunization 
Laminarin (300 or 600 
parts/million ppm) from 
L. digitata) 
Increased IL-6 and IL-8 gene expression in col
following LPS immunization;  
Reduced population of Enterobacteria in colon; 
Increased expression of mucin genes in ileum/
w
w
w
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Seaweed extracts are known to have immunomodulatory properties on the immune 
parameters in mice (Vetvicka & Ivyn, 2004) and pigs (Reilly et al., 2008; Leonard et al., 2010). 
Empirical evidences suggest that plant extracts may also offer benefits in stimulating the 
immune system, and thus, preventing disease in monogastric food animals (Wenk, 2003). A 
variety of plant-derived products have gained increasing interest as potential feed additives 
for poultry and swine (Windisch et al., 2008). Plants, and their bioactive components, are 
very diverse and their potential to enhance pig immunity and health has only been scarcely 
tested in vivo (Table 3). 
The most of these studies have used a mixture of compounds (Kommera et al., 2006; 
Manzanilla et al., 2006), which does not allow the investigation of the immunomodulating 
properties of a specific bioactive component. However, Chinese pharmacopoeia describes 
the use of numerous herbal formulations to cure wide variety of diseases. Among those, 
Bahzen is a medicine composed of eight different plants (Atractylodes ovata, Codonopsis 
pilosula, Poria cocos, Glycyrrhiza uralensis, Angelica sinensis, Ligusticum chuanxiong, Paeonia 
albiflora and Rehmannia glutinosa) whose extracts have been tested in vivo in pigs (Lien et al., 
2007). In spite positive image of medical plants in the public opinion a lack of data on the 
bioactive components of particular plants and the large diversity of their species, it has 
proved difficult to prepare extracts of equivalent potency, and thus the results of 
investigations on their influence on pig immunity remains inconclusive.  
The most promising results among IRMs tested have been obtained with animal by-
products of commercial slaughtering facilities such as purified porcine Igs or IgG (Valpotić 
et al., 1989a, b) and spay-dried porcine/bovine plasma (Coffey & Cromwell, 2001), whose 
positive effects would be provided by specific allogenic/xenogenic antibodies as well as by 
non-specific competition of glycan moieties of plasma glycoproteins with bacteria for 
intestinal receptors (Table 4). Namely, plasma from both porcine and bovine origins are 
characterized by a rich protein content, whose Igs can represent 24% to 25% (Niewold et al., 
2007), and the IgG fraction would appear to be the main component responsible for the 
growth-promoting properties (Pierce et al., 2005). The major positive effect of animal 
product such as bee glue or propolis given in-feed  (0.2%) is in reducing numbers of air-born 
bacteria in pig facilities (Bevilacqua et al., 1997) and the colonization of intestinal mucosa of 
weaned pigs by potentially harmful bacteria (Špoljarić, personal communication). The 
effects of spray-died porcine plasma (SDPP) on local intestinal immune responses have been 
widely studied in pigs (Table 4) and are concordant that SDPP prevents infiltration of GALT 
by immune cells and decreases jejunal proinflammatory cytokines, reflecting a lower 
antigenic challenge and suggesting that SDPP would be efficient in helping pigs fight 
against enteric infections (Jiang et al., 2000; Bosi et al., 2004; Nofrarias et al., 2006, 2007). 
Concerning systemic immune responses, a supplementation of the diet with SDPP did not 
modulate blood immune cells (Jiang et al., 2000; Nofrarias et al., 2006, 2007) or cytokines 
under basal conditions (Touchette et al, 2002), but when immunized with LPS, SDPP-fed 
pigs showed increased serum levels of proinfammatory cytokines associated with severe 
intestinal damage, suggesting that these pigs would be more susceptible to certain 
immunological challenges (Touchette et al., 2002). The growth-promoting properties of 
plasmas are more commonly observed with SDPP than from with that from bovine origin 
(vanDijk et al., 2001). The health-promoting properties of SDPP in pigs perorally challenged 
with an ETEC strain are usually reported as reduction in incidence/severity of postweaning 
diarrhea and growth promotion (Bosi et al., 2004; Niewold et al., 2007). Bovine colostrum 
has been shown to enhance intestinal mucosa restoration by stimulating migration of 
enterocytes and by decreasing apoptosis of apical epithelial cells in weaned pigs (Huguet et 
www.intechopen.com
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Microbial load/ 
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Propolis (vaporized 
in farm facility) 
Reduced no. of CFU in the air;   
Improved health of weaners. 
Weaning Spray-dried porcine 
plasma (SDPP; 10%) 
Decreased infiltration of GALT by macrophages and lymphoc
None on blood leukocyte count; 
Promotion of growth. 
Weaning/LPS-
immunization 
SDPP (7%) None on serum IFNγ or TNFα levels; 
Increased serum IFNγ or TNFα levels following immunization 
with LPS; 
Severe damage of intestinal mucosa. 
Weaning(LPS-
immunization 
SDPP (7%) Increased serum Il-6 and Il-1β following immunization with LPS;
Without influence on mRNA cytokine levels in liver, thymus
spleen; 
Decreased serum CRP, but not haptoglobin level.  
Weaning/F4+ 
ETEC-challenge 
SDPP (6%)  
 
Decreased expression of proinfammatory cytokines IL-8 an
Lower serum IgA level; 
Lower histopathologic score due to a better defense against 
infection. 
Increased average body weight. 
Weaning/F4+ 
ETEC-challenge 
SDPP (7%) None on serum IL-6 level; 
Prevention of growth retardation and clinical signs of diarrheal
disease.  
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IRM applied in-
feed or per os 
Effects on immune and production parameters 
Weaning SDPP (6%) Decreased infiltration of GALT by immune cells; 
None on no. of blood leukocytes; 
Promotion of growth. 
Weaning SDPP (6%) Decreased infiltration of GALT by immune cells; 
None on no. of blood leukocytes; 
Increased average body weight.. 
Weaning/Rotavirus + 
F4+ ETEC- challenges 
SDPP (8%) Reduced postweaning diarrhea and increased g
Increased specific antibody against LT of ETEC;
Decreased ETEC excretion. 
Competition of glycan moieties of glycoproteins
with intestinal receptors for F4 fimbrial antigens
Weaning Bovine colostrum 
(1g or 5g/day/pig 
for 3 weeks) 
Increased profiles of IL-2, IFNγ and IL-12 (Th1) or IL-4 
IL-10 cytokines (Th2) in IPP (more Th2 than Th1);
More pronounced Th1 profile of cytokines in JL
Decreased total no. of mononuclear cells in IPP, but t
proliferative responses were increased;  
Decreased CD21+ cell count and increased CD3+
subset 3 weeks postweaning; 
Systemic immune responses non-affected.   
Weaning Lactoferrin (0.1%)  Increased blood level of IL-2 and C4 component of 
complement; 
None on IL-1α or C3 blood concentrations; 
Enhanced proliferation of PBL and splenocytes 
with PHA or ConA; 
Increased serum levels of IgG, IgA and IgM, 
Prevention of diarrhea. 
Weaning SDPP (2.5 or 5.0%) Decreased level of TNFα in colon, but not in ileum;
Decreased level of IFNγ in ileum and colon; 
Reduced diarrheal disease.  
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3.2.2 Croatian experiences with IRMs in veterinary medicine 
In the following, the capacity of selected natural substances of microbial, fungal and animal 
origin to improve performances and the immune status of swine is reviewed based on in 
vivo or in vitro investigations performed in Croatian scientific community (Table 5). In our 
opinion, two main reasons are responsible for this research interest of a group of veterinary 
immunologists in Croatia: (i) at that time (the end of 1980’) literature dealing with IRMs as 
natural alternatives to in-feed AGPs and their impact on porcine immunity was scarce, and 
(ii) more recently (since 2006 in the EU) the total ban of in-feed AGPs and trends in research 
work on that topic may arise in the following years.  
Indeed, to accommodate to withdrawal of AGPs it now becomes urgent for Croatia as a 
member candidate and for Croatian scientific community to follow-up forthcoming EU 
regulations and keep-up with scientific trends in veterinary immunology in order to provide 
relevant health criteria and scientifically founded recommendations for alternatives to in-
feed AGPs. 
For each type of substance, only major elements concerning experimental designs, such as 
the immune/performance parameters which have been studied by differentiating the 
systemic and local intestinal immune responses were given. In spite of the fact that in most 
of the experiments in vivo application of IRMs has been performed parenterally, the gut 
mucosal immune cells have been prevalently studied. Thus, immune reactions after such 
applications of natural IRMs cannot directly be linked to a defined site of origin. So far, it is 
often difficult to explain whether their reaction pattern depends on intestinal mucosal or 
systemic immune responses. However, intestinal mucosal immune responses can occur 
independently of systemic immunity (Hannant, 2002).  
Considering experimental designs in the context of testing IRMs (Table 5) it is necessary to 
mention that in the most cases stressful events such as birth and weaning (accompanied 
with ETEC challenge and non-ETEC vaccination) have been used as a model systems. To 
help pigs to cope with postweaning transition, various nutritional approaches have been 
proposed, including supplementation the diet with substances that increase appetence or 
have anti-microbial and/or immunostimulating properties (Lalles et al., 2007). Amongst the 
alternatives to in-feed AGPs, the IRMs, including preparation of inactivated Parapoxvirus 
ovis (Valpotić et al., 1993; Grgić et al., 1995; Šver et al., 1996a; Krsnik et al., 1999, Šperanda et 
al., 2008) and yeast derivatives such as Progut® (mixture of ǂ-mannans, ǃ-glucans, 
nucleotides and peptides) and BioMOS® (ǂ-mannan oligosaccharide) are attracting greater 
attention (Šperanda et al., 2008, Valpotić, 2009; Špoljarić et al., 2011). Indeed, the correct 
functional development of the gut and GALT is of crucial importance in controlling 
potential pathogens during neonatal and postweaning period. Weaning affects the ontogeny 
of immune functions, largely as a consequence of the withdrawal of milk and catabolism of 
colostral antibodies, which have important implications for passively modulating immune 
responses through both suppressive and enhancing pathways. In accordance with this 
phenomenon, plasma-derived porcine IgG acted in vitro as an IRM on PBL reactivity to T- or 
B-cell mitogens from weaned pigs (Valpotić et al., 1989). 
Finally, to assess the impact of in-feed IRMs simultaneously on immunity and on 
performances and health, the pigs used in these experiments (Table 5) were kept under 
commercial farm conditions implying that they were exposed to immune/infectious 
challenges. Thus, the studies performed may reflect immune functions and dysfunctions 
occurring following exogenous immunomodulation.  
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4. Conclusions: Potentials and limitations 
Considerable efforts have been focused to understanding of enteric infectious diseases, their 
diagnosis, including biology of pathogens, host resistance and therapy in intensive large-
scale production of food animals, particularly pigs. Conversely, little is known on 
prevention of such diseases through immunomodulatory and dietary strategies because 
these problems have been overcome thus far by adding sub-therapeutic doses of AGPs in-
feed in swine industry to enhance production efficiency. The AGPs were used not only to 
improve growth but also to control enteric infections during critical periods such as birth 
and weaning. Numerous reports have suggesting that vast variety of substances of natural 
origin termed IRMs, including bioactive components of feed, i. e. nutraceuticals (prebiotics, 
probiotics, minerals) and of organisms, including their products or derivatives, i. e. 
immunomodulators (microbiotics, fungibiotics, phytobioticy, zoobiotics) can modulate 
(stimulate, suppress or restore) nonspecific and specific immunity in young pigs. Such 
strategy underlying pharmacological manipulation of the immune system, i. e. 
immunomodulation is to identify parameters of the host response that will indicate 
enhancement/suppression or restoration to a level of an “optimal immune response”, to 
allow the host better combat against invading microbes during the course of infection. With 
growing knowledge of porcine immune system and its endogenous modulation, it has been 
stated in the literature that exogenous modulation using broad spectrum of IRMs represents 
an important prophylactic/therapeutic approach in prevention/treatment of both stress- 
and microbial-induced disorders accompanied birth or weaning, particularly enteric 
infections. Such substances should be effective in protection of gut health, and at same time 
harmless for animal and environment, and should be capable of stimulating/restoring of 
gut physiological and immune functions, and thus, could be particularly important during 
development and maturation of intestinal mucosal immune system. However, it is essential 
to select fully evaluated agent which may act either as an IRM or synergistically as an 
adjuvant with vaccines. 
As highlighted in this chapter, substances whose immunomodulatory properties often issue 
from in vitro studies are not exhibiting putative potentials when tested in vivo, particularly 
as feed additives. Namely, studies where variety of IRMs (such as yeast derivatives or plant 
extracts) have been fed to pigs have shown inconsistent results, suggesting that their ability 
to target particular immune cells through the oral route is questionable. The main causes 
are: the influence of environment, feed content, present commensals, possible inflammation 
or ischemia type injuries, which may shift the mucosal immune response as well as the 
whole gut functions. Consequently, influence of IRMs on pig immunity remains 
inconclusive. The most promising results to date have been obtained with animal by-
products and precuts, such as spray-dried plasma or propolis, respectively. The 
heterogeneity of these experiments can partly explain the discrepancies on their efficacy due 
to: (i) variable composition of feed additives, (ii) different time of supplementation, (iii) 
diversity of experimental designs or measured parameters, and (iv) the level of additive in 
the final diet often remains unknown as well as (v) the composition of additive itself is not 
revealed/defined. Moreover, while the effects of in-feed IRMs on systemic immunity are 
quite well documented, the local intestinal immune responses have only receive little 
attention despite the fact that the study of systemic immune responses may not reflect 
immune functions following dietary treatments with IRMs occurring in the GALT. In spite 
of all these experiments in the context of testing immunomodulatory compounds of various 
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origin, one main problem is to define what “optimal” immune functions should be targeted. 
For instance, if there is evidence that immunosuppressive effect is expected to prevent 
potentially damaging immune-mediated reactions, such as chronic inflammation, 
stimulation of the active immunity is not required for development and education of the 
immune system. This is particularly true for GALT where a homeostatic balance has to be 
reached to both tolerate harmless antigens from commensal bacteria or diet, and eliminate 
harmful antigens from pathogenic microbes. The definition of an “optimal” immune 
function is thus highly complex, and in the context of food animal production, it could be 
defined as the one that offers both the best growth and health status to animal. This, 
however, implies that pigs are exposed to normal commercial rearing conditions in which 
they are submitted to immune/infectious challenges in order to objectively assess the 
impact of in-feed IRMs simultaneously on immunity and on performances and health.  
In the future, the effects of in-feed/oral additives on the development of immune responses 
in the GALT should be more largely documented, as their effects are mainly expected in this 
compartment. Thus, such studies should include: 
- well characterized relevant model systems of young pigs on multidisciplinary basis, 
and usable for an uniform evaluation of their performances, gut health criteria and 
optimal functioning of the GALT; 
- fully defined IRMs, particularly their bioactive substance(s); 
- pharmacokinetic studies intended to know the fate of these substances in the organism, 
in order to precise their site of action and physiological/immunological effects; 
- scientifically founded statement regarding relationship between immunomodulatory 
effects induced by dietary IRMs and health status of pigs, as the final goal of using such 
substances in pig nutrition is to promote their performance, health and welfare.  
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